{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T14:32:31Z","timestamp":1714141951931},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,5,15]]},"DOI":"10.2169\/internalmedicine.0428-22","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T22:15:42Z","timestamp":1664316942000},"page":"1537-1540","source":"Crossref","is-referenced-by-count":1,"title":["Subcutaneous Panniculitis-like T-cell Lymphoma with a &lt;i&gt;HAVCR2&lt;\/i&gt; Mutation Diagnosed after 10 Years of Treatment with Glucocorticoids and Cyclosporine as Lupus Panniculitis"],"prefix":"10.2169","volume":"62","author":[{"given":"Yoshiki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Noda","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sawaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Shinoki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Hospital Organization Mie Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imai","sequence":"additional","affiliation":[{"name":"Pathology Division, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Tawara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. L\u00f3pez-Lerma I, Pe\u00f1ate Y, Gallardo F, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients. J Am Acad Dermatol 79: 892-898, 2018.","DOI":"10.1016\/j.jaad.2018.05.1243"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. He A, Kwatra SG, Kazi N, et al. Atypical lymphocytic lobular panniculitis: an overlap condition with features of subcutaneous panniculitis-like T-cell lymphoma and lupus profundus. BMJ Case Rep 2016.","DOI":"10.1136\/bcr-2016-215335"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wu X, Subtil A, Craiglow B, et al. The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitis-like T-cell lymphoma in the same patient. JAAD Case Rep 4: 179-184, 2018.","DOI":"10.1016\/j.jdcr.2017.08.021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 133: 1703-1714, 2019.","DOI":"10.1182\/blood-2018-11-881268"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Michonneau D, Petrella T, Ortonne N, et al. Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy. Acta Derm Venereol 97: 358-364, 2017.","DOI":"10.2340\/00015555-2543"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gayden T, Sepulveda FE, Khuong-Quang DA, et al. Germline <i>HAVCR2<\/i> mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet 50: 1650-1657, 2018.","DOI":"10.1038\/s41588-018-0251-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. LeBlanc RE, Tavallaee M, Kim YH, et al. Useful parameters for distinguishing subcutaneous panniculitis-like T-Cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol 40: 745-754, 2016.","DOI":"10.1097\/PAS.0000000000000596"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sitthinamsuwan P, Pattanaprichakul P, Treetipsatit J, et al. Subcutaneous panniculitis-like T-cell lymphoma versus lupus erythematosus panniculitis: distinction by means of the periadipocytic cell proliferation index. Am J Dermatopathol 40: 567-574, 2018.","DOI":"10.1097\/DAD.0000000000001173"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Machan S, Rodr\u00edguez M, Alonso-Alonso R, et al. Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes. Leuk Lymphoma 62: 2130-2140, 2021.","DOI":"10.1080\/10428194.2021.1901098"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. LeBlanc RE, Lansigan F. Unraveling subcutaneous panniculitis-like T-cell lymphoma: an association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis. J Cutan Pathol 48: 572-577, 2021.","DOI":"10.1111\/cup.13863"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/10\/62_0428-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T03:26:30Z","timestamp":1684553190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/10\/62_0428-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0428-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"0428-22"}}